Delivery Order SPE2DB25D3022-SPE2DB25FWBUZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/ml autoinjector on August 15, 2025, with a ceiling value of $3,524.56. This is a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Taltz is a biologic medication used to...
- The Defense Logistics Agency awarded a $24,730.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Taltz 80 mg/ml autoinjector. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 18, 2025, and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Taltz 80 mg/ml autoinjector medication with a ceiling value of $17,030.96. This firm fixed-price delivery order, which is set to conclude on August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.31 to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/mL autoinjector on October 15, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under an existing indefinite delivery contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $46,054.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Taltz 80 mg/mL auto-injector (2-pack) pharmaceutical product. The contract, which is set to be completed by August 1, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of TALTZ 80 mg/ml auto-injector two-packs with a ceiling value of $8,391.13. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $17,581.86 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Taltz 80 mg/ml auto-injector medication. This firm fixed-price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Taltz 80 mg/ml autoinjectors with a ceiling value of $4,197.10. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, reflecting a short fulfillment timeline for this pharmaceutical product. The contract utilizes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,965.18 to AmerisourceBergen Drug Corp for Taltz 80 mg/ml auto-injector two-packs on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Taltz is a biologic medication used to treat inflammatory conditions, and this delivery...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWBUZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Taltz 80 mg/ml autoinjector at a ceiling value of $3,564.93. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Taltz is a biologic medication used to treat various autoimmune and inflammatory conditions, and this delivery order represents a standard pharmaceutical supply transaction within the company's broader federal healthcare vendor relationships. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen fulfills extensive pharmaceutical and medical supply requirements across multiple therapeutic domains for military and veteran healthcare systems. The company's portfolio demonstrates consistent capability in supplying specialty medications, brand-name and generic drugs, and specialized medical devices to support Defense Health Agency operations and other federal healthcare entities. This particular delivery order exemplifies the routine operational execution of AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 6/25/25 |